M

Mereo BioPharma Group plc
D

MREO

0.32790
USD
-0.00
(-1.06%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
52,338,942
أصول ذات صلة المقالات
المزيد

العنوان: Mereo BioPharma Group plc

القطاع: Healthcare
الصناعة: Biotechnology
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its tworare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).